“We believe our findings are a positive step forward in helping millions of people facing heart failure,” says Ahmed Mahmoud, professor of cell and regenerative biology.
Science & Technology
Researchers find a better way to measure consciousness
A new study of brain activity could prevent the potential trauma of patients under anesthesia regaining some awareness during medical procedures.
Individualized brain cell grafts reverse Parkinson’s symptoms in monkeys
UW researchers say the stem cell treatment is an “extremely powerful” step toward a treatment for millions of human Parkinson’s patients.
A new way to help the immune system fight back against cancer
“We believe we are launching a new cancer therapy field here,” says Jamey Weichert, professor of radiology. “It’s very exciting, and the research team is incredible.”
Gene-edited monkey embryos give researchers new way to study HIV cure
A gene that cured a man of HIV a decade ago has been successfully added to developing monkey embryos in an effort to study more potential treatments for the disease.
Early mutation in SARS-CoV-2 virus in Europe led to its domination worldwide
A study shows that the mutant virus is more easily transmitted and grows better within hosts, likely aiding its dominance. The mutation, researchers say, should not interfere with the effectiveness of vaccines against the virus.
First relatives of rubella virus discovered in bats in Uganda and mice in Germany
Neither of the new viruses is known to infect people, but the findings reinforce the important work scientists are undertaking to study the effects of a changing environment on human and animal diseases.
Stem cells can repair Parkinson’s-damaged circuits in mouse brains
UW neuroscientists led by Su-Chun Zhang found that neurons derived from stem cells can connect with native neurons and restore motor functions. But more research is needed to translate the findings from mice to people.
New vaccine strategy harnesses ‘foot soldier’ T-cells to provide protection against influenza
Researchers believe the same approach can be applied to several other respiratory pathogens, including the novel coronavirus that causes COVID-19.
New COVID-19 clinical trials at UW–Madison and UW Health will study antibody approach
The trials center around an “antibody cocktail” called REGN-COV2, which was created by the New York-based pharmaceutical company Regeneron.